A detailed history of Iag Wealth Partners, LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Iag Wealth Partners, LLC holds 927 shares of EOLS stock, worth $10,669. This represents 0.0% of its overall portfolio holdings.

Number of Shares
927
Previous 927 -0.0%
Holding current value
$10,669
Previous $10,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 04, 2021

SELL
$7.36 - $13.67 $20,946 - $38,904
-2,846 Reduced 75.43%
927 $8,000
Q1 2021

Apr 29, 2021

SELL
$3.2 - $16.51 $96 - $495
-30 Reduced 0.79%
3,773 $50,000
Q4 2019

Feb 11, 2021

BUY
$11.58 - $17.37 $44,038 - $66,058
3,803 New
3,803 $47,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $646M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Iag Wealth Partners, LLC Portfolio

Follow Iag Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iag Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iag Wealth Partners, LLC with notifications on news.